150 related articles for article (PubMed ID: 32794566)
1. Circulating Procollagen Type III N-Terminal Peptide and Physical Function in Adults from the Long Life Family Study.
Santanasto AJ; Cvejkus RK; Wojczynski MK; Marron MM; Schupf N; Christensen K; Thyagarajan B; Zmuda JM
J Gerontol A Biol Sci Med Sci; 2021 Jun; 76(7):1273-1279. PubMed ID: 32794566
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma procollagen type III N-terminal peptide (P3NP) levels and physical performance in elderly men: The Korean Frailty and Aging Cohort Study (KFACS).
Shin HE; Kim M; Won CW
Exp Gerontol; 2021 Oct; 154():111523. PubMed ID: 34425203
[TBL] [Abstract][Full Text] [Related]
3. N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone.
Bhasin S; He EJ; Kawakubo M; Schroeder ET; Yarasheski K; Opiteck GJ; Reicin A; Chen F; Lam R; Tsou JA; Castaneda-Sceppa C; Binder EF; Azen SP; Sattler FR
J Clin Endocrinol Metab; 2009 Nov; 94(11):4224-33. PubMed ID: 19837911
[TBL] [Abstract][Full Text] [Related]
4. Muscle quality, physical performance, and comorbidity are predicted by circulating procollagen type III N-terminal peptide (P3NP): the InCHIANTI follow-up study.
Pellegrino R; Paganelli R; Di Iorio A; Bandinelli S; Moretti A; Iolascon G; Sparvieri E; Tarantino D; Ferrucci L
Geroscience; 2024 Feb; 46(1):1259-1269. PubMed ID: 37532926
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional associations among P3NP, HtrA, Hsp70, Apelin and sarcopenia in Taiwanese population.
Chen YY; Chiu YL; Kao TW; Peng TC; Yang HF; Chen WL
BMC Geriatr; 2021 Mar; 21(1):192. PubMed ID: 33743591
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults.
Fragala MS; Jajtner AR; Beyer KS; Townsend JR; Emerson NS; Scanlon TC; Oliveira LP; Hoffman JR; Stout JR
J Cachexia Sarcopenia Muscle; 2014 Jun; 5(2):139-48. PubMed ID: 24197815
[TBL] [Abstract][Full Text] [Related]
7. Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease.
Hamza RT; Ahmed AY; Rezk DG; Hamed AI
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1345-1352. PubMed ID: 27442361
[TBL] [Abstract][Full Text] [Related]
8. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis.
Babbs C; Smith A; Hunt LP; Rowan BP; Haboubi NY; Warnes TW
Lancet; 1988 May; 1(8593):1021-4. PubMed ID: 2896870
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
[TBL] [Abstract][Full Text] [Related]
10. Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
Berry SD; Ramachandran VS; Cawthon PM; Gona P; McLean RR; Cupples LA; Kiel DP
J Frailty Aging; 2013; 2(3):129-34. PubMed ID: 24244927
[TBL] [Abstract][Full Text] [Related]
11. Trunk fat mass correlates with balance and physical performance in a community-dwelling elderly population: Results from the Korean Frailty and aging cohort study.
Kim JH; Chon J; Soh Y; Han YR; Won CW; Lee SA
Medicine (Baltimore); 2020 Feb; 99(9):e19245. PubMed ID: 32118729
[TBL] [Abstract][Full Text] [Related]
12. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
van der Voort EAM; Wakkee M; Veldt-Kok P; Darwish Murad S; Nijsten T
Br J Dermatol; 2017 Jun; 176(6):1599-1606. PubMed ID: 27925155
[TBL] [Abstract][Full Text] [Related]
13. Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.
Khoo EY; Stevenson MC; Leverton E; Cross R; Eriksson JW; Poucher SM; Spendlove I; Morris PG; Macdonald IA; Mansell P; Aithal GP
Dig Dis Sci; 2012 Nov; 57(11):3017-25. PubMed ID: 22592631
[TBL] [Abstract][Full Text] [Related]
14. Serum N terminal procollagen III fragment: a predictive marker of joint destruction in rheumatoid arthritis?
Tebib JG; Viguier P; Noel E; Colson F; Barbier Y; Bouvier M
Clin Rheumatol; 1992 Dec; 11(4):502-7. PubMed ID: 1486740
[TBL] [Abstract][Full Text] [Related]
15. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
[TBL] [Abstract][Full Text] [Related]
16. Association of Family History of Exceptional Longevity With Decline in Physical Function in Aging.
Ayers E; Barzilai N; Crandall JP; Milman S; Verghese J
J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1649-1655. PubMed ID: 28379407
[TBL] [Abstract][Full Text] [Related]
17. Jump power, leg press power, leg strength and grip strength differentially associated with physical performance: The Developmental Epidemiologic Cohort Study (DECOS).
Winger ME; Caserotti P; Ward RE; Boudreau RM; Hvid LG; Cauley JA; Piva SR; Harris TB; Glynn NW; Strotmeyer ES
Exp Gerontol; 2021 Mar; 145():111172. PubMed ID: 33245997
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren.
Crofton PM; Wade JC; Taylor MR; Holland CV
Clin Chem; 1997 Sep; 43(9):1577-81. PubMed ID: 9299936
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of NT-proBNP levels in the acute phase of sepsis on lower long-term physical function and muscle strength in sepsis survivors.
Custodero C; Wu Q; Ghita GL; Anton SD; Brakenridge SC; Brumback BA; Efron PA; Gardner AK; Leeuwenburgh C; Moldawer LL; Petersen JW; Moore FA; Mankowski RT
Crit Care; 2019 Jun; 23(1):230. PubMed ID: 31234943
[TBL] [Abstract][Full Text] [Related]
20. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
Khan S; Subedi D; Chowdhury MM
Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
